Department of Obstetrics and Gynaecology, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Department of Medical Statistics and Biomathematics, University Medical Centre Mannheim, Heidelberg University, Mannheim, Germany.
Arch Gynecol Obstet. 2019 Apr;299(4):1121-1130. doi: 10.1007/s00404-018-5025-9. Epub 2019 Jan 4.
Patient comfort and preference have steadily gained attention in radio-oncologic treatment of breast cancer. Therefore, the purpose of this investigation was to further explore patient preferences in choosing between intraoperative radiotherapy (IORT) and external beam radiotherapy (EBRT).
We prospectively analysed data of 101 women, who were candidates for breast-conserving surgery with adjuvant radiotherapy. A two-part video was shown to patients: an educational section about EBRT/IORT, followed by a preference elicitation section focusing on additional accepted risk (AAR) of recurrence after either treatment. Furthermore, participants completed a questionnaire to identify factors that influence patient preference of radiation modality.
The data demonstrate that 42.5% of patients would accept additional risk of recurrence for IORT versus 9% AAR for EBRT, while 48.5% of patients would not accept any additional risk, yet would choose IORT over EBRT if risks of recurrence were equivalent. When combining patient preferences and the results from the questionnaire, no single socio-economic/-demographic factor was found to significantly correlate with AAR of IORT.
Our study confirms the existence of subgroups of breast cancer patients who would accept an additional risk of recurrence associated with choice of radiation modality to receive a single dose of IORT as adjuvant radiotherapy for breast cancer instead of EBRT over several weeks; yet our data fail to identify a single factor significantly associated with these patient preferences and, therefore, helpful for individualised decision-making processes.
在乳腺癌的放射肿瘤治疗中,患者的舒适度和偏好已逐渐受到关注。因此,本研究的目的是进一步探讨患者在选择术中放疗(IORT)和外部束放疗(EBRT)之间的偏好。
我们前瞻性分析了 101 名接受保乳手术和辅助放疗的女性患者的数据。向患者展示了两段视频:一段是关于 EBRT/IORT 的教育部分,然后是一段侧重于两种治疗方法后复发额外接受风险(AAR)的偏好评估部分。此外,参与者还完成了一份问卷,以确定影响患者对放射治疗方式偏好的因素。
数据表明,42.5%的患者会接受 IORT 的额外复发风险,而只有 9%的患者会接受 EBRT 的 AAR,而 48.5%的患者不会接受任何额外的风险,但如果复发风险相等,他们会选择 IORT 而不是 EBRT。当结合患者的偏好和问卷的结果时,没有发现任何单一的社会经济/人口统计学因素与 IORT 的 AAR 显著相关。
我们的研究证实了存在亚组的乳腺癌患者,他们会接受与选择放射治疗方式相关的额外复发风险,以接受单次 IORT 作为乳腺癌的辅助放疗,而不是接受数周的 EBRT;然而,我们的数据未能确定与这些患者偏好显著相关的单一因素,因此,对个体化决策过程没有帮助。